summary
Introduced
In Committee
Crossed Over
Passed
Dead
Introduced Session
112th Congress
Bill Summary
Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research; (2) identification of research questions that have not been adequately addressed; and (3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions. Requires the Director to develop the framework within 18 months and review and update it every 5 years. Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer. Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act. Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.
AI Summary
This bill, the Recalcitrant Cancer Research Act of 2012, requires the Director of the National Cancer Institute (NCI) to create a comprehensive research plan, known as a scientific framework, for cancers that are difficult to treat, defined as those with a five-year survival rate below 50%. This framework must include a review of current research, identify unanswered scientific questions, and propose actions and benchmarks to measure progress in advancing research. The NCI Director must develop this framework within 18 months and update it every five years. The bill also mandates the identification of at least two specific recalcitrant cancers with a survival rate below 20% and causing at least 30,000 deaths annually in the U.S. within six months, with the possibility of identifying additional such cancers. To assist in developing these frameworks, working groups of experts will be convened for each identified cancer, and the NCI Director will consider these frameworks when recommending special funding for grant applications.
Committee Categories
Health and Social Services
Sponsors (24)
Daniel Akaka (D),
Richard Blumenthal (D),
Roy Blunt (R),
Scott Brown (R),
Sherrod Brown (D),
Susan Collins (R),
Dianne Feinstein (D),
Chuck Grassley (R),
Mark Kirk (R),
Frank Lautenberg (D),
Patrick Leahy (D),
Joseph Lieberman (I),
Richard Lugar (R),
Barbara Mikulski (D),
E. Benjamin Nelson (D),
Mark Pryor (D),
Jack Reed (D),
Marco Rubio (R),
Jeanne Shaheen (D),
Debbie Stabenow (D),
Jon Tester (D),
Mark Warner (D),
Sheldon Whitehouse (D),
Roger Wicker (R),
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 09/19/2012)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/112th-congress/senate-bill/3560/all-info | 04/25/2013 |
| Bill | http://gpo.gov/fdsys/pkg/BILLS-112s3560is/pdf/BILLS-112s3560is.pdf.pdf | 02/02/2013 |
Loading...